Compare EQ & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQ | QUCY |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.4M | 86.6M |
| IPO Year | 2018 | 2021 |
| Metric | EQ | QUCY |
|---|---|---|
| Price | $1.24 | $1.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.56 | N/A |
| AVG Volume (30 Days) | ★ 543.3K | 454.5K |
| Earning Date | 11-12-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.68 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,095,000.00 | $537,080.00 |
| Revenue This Year | N/A | $281.69 |
| Revenue Next Year | N/A | $123.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.19 | $0.30 |
| 52 Week High | $6.20 | $4.93 |
| Indicator | EQ | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 25.58 | 40.81 |
| Support Level | N/A | $1.03 |
| Resistance Level | $1.51 | $1.49 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 0.00 | 33.33 |
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.